SPDR S&P Biotech ETF
146 hedge funds and large institutions have $2.16B invested in SPDR S&P Biotech ETF in 2014 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
17% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 42
13% more funds holding
Funds holding: 129 → 146 (+17)
52% less call options, than puts
Call options by funds: $65.8M | Put options by funds: $137M
Holders
146
Holding in Top 10
7
Calls
$65.8M
Puts
$137M
Top Buyers
| 1 | +$174M | |
| 2 | +$17.9M | |
| 3 | +$13.1M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$6.05M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$5.57M |
Top Sellers
| 1 | -$43.1M | |
| 2 | -$18.3M | |
| 3 | -$18.2M | |
| 4 |
Goldman Sachs
New York
|
-$16.3M |
| 5 |
SG Americas Securities
New York
|
-$4.76M |